about
Notes for developing a molecular test for the full characterization of circulating tumor cellsClinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment.Effects of glucose-regulated protein94 (Grp94) on Ig secretion from human blood mononuclear cellsRetaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients.Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to sunitinib in metastatic renal cancer.Hypoxia inducible factor-1alpha inactivation unveils a link between tumor cell metabolism and hypoxia-induced cell death.Differential expression of constitutive and inducible proteasome subunits in human monocyte-derived DC differentiated in the presence of IFN-alpha or IL-4.Circulating and disseminated tumor cells in the clinical management of breast cancer patients: unanswered questions.Grp94 in complexes with IgG is a soluble diagnostic marker of gastrointestinal tumors and displays immune-stimulating activity on peripheral blood immune cells.Possible applications of circulating tumor cells in patients with non small cell lung cancer.Frequency of a mutated CCR-5 allele (delta32) among Italian healthy donors and individuals at risk of parenteral HIV infection.M30 neoepitope expression in epithelial cancer: quantification of apoptosis in circulating tumor cells by CellSearch analysis.The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects.Expression from cell type-specific enhancer-modified retroviral vectors after transduction: influence of marker gene stability.Genetic control of the CD4/CD8 T-cell ratio in humans.In vitro malignant progression of cells derived from Abelson murine leukaemia virus-induced thymic lymphomas.Inhibition of immunoglobulin secretion from peripheral blood mononuclear cells by glucose-regulated protein94 (Grp94) in allergic subjects.Standardization of in vitro synthesis and detection of HIV-1-specific antibodies.Infection of simian B lymphoblastoid cells with simian immunodeficiency virus is associated with upregulation of CD23 and CD40 cell surface markers.A CD3+CD8+ T cell population lacking CD5 antigen expression is expanded in peripheral blood of human immunodeficiency virus-infected patients.Critical issues in the clinical application of liquid biopsy in non-small cell lung cancer.Liquid biopsy for monitoring anaplastic lymphoma kinase inhibitors in non-small cell lung cancer: two cases compared.Monitoring and Characterization of Circulating Tumor Cells (CTCs) in a Patient With EML4-ALK-Positive Non-Small Cell Lung Cancer (NSCLC).Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting.Clonal heterogeneity of melanoma in a paradigmatic case study: future prospects for circulating melanoma cellsThe Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer ImmunotherapyFirst-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel–Lindau (VHL) disease: clinical outcome and patterns of radiological responseOnset of HIV-1 antibody production after highly active antiretroviral therapy in a seronegative HIV-1-infected childToward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap)Detection and Prognostic Relevance of Circulating and Disseminated Tumour Cell in Dogs with Metastatic Mammary Carcinoma: A Pilot StudyCD4: CD8 ratio and HIV infection: the "tap-and-drain' hypothesisQuantitative and qualitative analysis of anti-tetanus toxoid antibody response in the elderly. Humoral immune response enhancement by thymostimulinIn vitro spontaneous production of anti-SIV antibodies is a reliable tool in the follow-up of protection of SIV-vaccinated monkeysCD4 and CD8 T lymphocyte inheritance. Evidence for major autosomal recessive genesEffect of rIL-2 treatment on anti-tetanus toxoid response in the elderlyTCR expression and clonality analysis in peripheral blood and lymph nodes of HIV-infected patientsB cell activation in peripheral blood and lymph nodes during HIV infectionA lymphotactin-producing monoclonal T-cell lymphoproliferative disorder with extreme lymphocytopenia and progressive leukoencephalopathySingle tube liquid biopsy for advanced non-small cell lung cancer
P50
Q26778913-46AB7DFD-014E-48B9-B882-EF10BF8054F8Q30779447-7DF3D5F5-6EC7-471A-8C06-B09A6F8C155BQ34573041-3D021919-48BE-47B3-A728-B3F417A4F693Q34797231-73275BAB-85E2-4008-99FF-19802CC8F2DDQ34971918-7D6CE8A4-88F8-4A09-A182-70D36794D434Q36387861-4533817A-8C9A-415E-A35A-5621B5071003Q36891578-3CE9509A-DB4A-4DDF-9C74-28EC163A3696Q37354906-A78E85FE-160B-462F-929E-F34E376105AFQ37465975-5334A1C4-35E0-43CF-89CA-A29A262A27DDQ37687316-D0512317-6A66-4FB6-8C25-DB5195A2ED91Q38875351-D43E67F7-706B-4C4E-AA82-8355D417A33BQ39622285-638C1D15-6494-41C5-9EE8-063BD665C473Q39639547-8A39AD61-D1C3-43CE-A5C1-84029CB6BB3BQ39960772-C07E2C89-B5ED-4312-BADF-B8A073C1D99CQ40748055-9398180B-A8B4-4E40-8699-3313AE504B44Q41653812-82B41CCC-7873-400E-B12B-599F74BBCFE7Q42175378-29A68E16-F1D7-4AEC-B4E6-040EC74E0950Q42500995-49A2EF65-B639-41DF-885B-ED993DA99E98Q45220915-58DF92D4-4295-4617-891C-49A078279EAEQ45731070-8FFF58EF-2B1A-40F6-B9EC-7CE88089E5E9Q45788416-E34B1BFE-21B6-4835-9AA9-5088E25F018BQ47104064-2D0ED572-D0D2-4591-89EB-752B7785ACD8Q47134673-BDD81C92-1438-4F30-B036-6438659BE400Q53778077-BB4CC24F-567E-4956-AE37-4A7F7E26EE5AQ54444545-F783EBF3-92EA-4003-9D44-C2B398D8C533Q57157331-B28895EE-28A8-40E0-8A3F-15AC322EAAC6Q57166654-F064EA06-B659-4C51-A237-2832FA920F38Q57578654-E169B024-9959-47C5-9C03-BB1E0616023CQ58276475-FB7E6362-A784-4827-B62A-D7492EC5D2FAQ61447457-BF1A50ED-918F-47E7-BFC2-EC36CF24AE5BQ64245103-EBEA668F-FC4D-45CC-BD81-2D4BC6CC986BQ71648979-31ED541E-FF4B-4EB6-B026-B5B2F593C719Q72746085-94ECFBAB-F523-448B-BBC7-97C167AC7D67Q72782433-054F4012-7D37-46E0-9401-4F5D19B96D05Q73137031-4168C198-84BD-475A-B358-2C152756CCC9Q73194882-10E87BE1-7FAB-4298-82CC-A214489776C8Q74074352-5B750D79-7558-4D2D-BE62-714C5004B5D3Q74230041-F9022461-1BB2-4CD1-92BC-37DC9C5C701BQ80147961-C68A4B15-F666-483D-8641-620B95282248Q90400522-A2D68503-2DB1-4FF2-A47A-7989585BF6D7
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rita Zamarchi
@ast
Rita Zamarchi
@en
Rita Zamarchi
@es
Rita Zamarchi
@nl
type
label
Rita Zamarchi
@ast
Rita Zamarchi
@en
Rita Zamarchi
@es
Rita Zamarchi
@nl
prefLabel
Rita Zamarchi
@ast
Rita Zamarchi
@en
Rita Zamarchi
@es
Rita Zamarchi
@nl
P106
P1153
6603920789
P21
P31
P496
0000-0001-6435-2257